WallStSmart

Bruker Corporation (BRKR)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 647% more annual revenue ($25.84B vs $3.46B). SYK leads profitability with a 14.4% profit margin vs -0.3%. BRKR appears more attractively valued with a PEG of 1.52. SYK earns a higher WallStSmart Score of 63/100 (C+).

BRKR

Hold

35

out of 100

Grade: F

Growth: 4.7Profit: 3.5Value: 5.0Quality: 5.5
Piotroski: 3/9Altman Z: 1.71

SYK

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 7.5Value: 3.3Quality: 6.5
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BRKRUndervalued (+5.0%)

Margin of Safety

+5.0%

Fair Value

$44.67

Current Price

$53.41

$8.74 discount

UndervaluedFair: $44.67Overvalued
SYKSignificantly Overvalued (-47.2%)

Margin of Safety

-47.2%

Fair Value

$228.91

Current Price

$339.03

$110.12 premium

UndervaluedFair: $228.91Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BRKR0 strengths · Avg: 0/10

No standout strengths identified

SYK3 strengths · Avg: 8.3/10
Market CapQuality
$128.87B9/10

Large-cap with strong market position

Operating MarginProfitability
27.0%8/10

Strong operational efficiency at 27.0%

EPS GrowthGrowth
44.1%8/10

Earnings expanding 44.1% YoY

Areas to Watch

BRKR4 concerns · Avg: 3.8/10
PEG RatioValuation
1.524/10

Expensive relative to growth rate

Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

SYK3 concerns · Avg: 3.7/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

P/E RatioValuation
35.3x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : BRKR

BRKR has a balanced fundamental profile.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap, Operating Margin, EPS Growth.

Bear Case : BRKR

The primary concerns for BRKR are PEG Ratio, Revenue Growth, Altman Z-Score.

Bear Case : SYK

The primary concerns for SYK are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

BRKR profiles as a turnaround stock while SYK is a value play — different risk/reward profiles.

BRKR carries more volatility with a beta of 1.29 — expect wider price swings.

SYK is growing revenue faster at 9.4% — sustainability is the question.

SYK generates stronger free cash flow (415M), providing more financial flexibility.

Bottom Line

SYK scores higher overall (63/100 vs 35/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bruker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Bruker Corporation develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States, Europe, Asia Pacific, and internationally. The company is headquartered in Billerica, Massachusetts.

Visit Website →

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?